Search Results - "Walker, J.L"

Patient-reported outcomes in GOG 252: NRG Oncology Study of IV vs IP chemotherapy for ovarian, fallopian, or peritoneal carcinoma by Walker, J.L, Wenzel, L, Huang, H, Brady, M.F

Get full text

The impact of obesity on pathologic features and survival with endometrial cancer: A Gynecologic Oncology Group (GOG) LAP2 ancillary data study by Java, J, Moore, K.N, Walker, J.L

Get full text

Operative outcomes among a geriatric population of endometrial cancer patients: An ancillary data analysis of Gynecologic Oncology Group study LAP2 by Java, J, Moore, K.N, Walker, J.L

Get full text

Complications and surgical staging of endometrial cancer with respect to obesity: A Gynecologic Oncology Group LAP2 ancillary data study by Java, J, Moore, K.N, Walker, J.L

Get full text

Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma? by Nugent, E.K, Bishop, E.A, Mathews, C.A, Moxley, K.M, Tenney, M, Mannel, R.S, Walker, J.L, Moore, K.N, Landrum, L.M, McMeekin, D.S

“…Abstract Objectives Controversy continues over the importance of lymph node (LN) status in treating and predicting recurrence in endometrial cancer. Several…”
Get full text

Regional-specific alterations in cell–cell junctions, cytoskeletal networks and myosin-mediated mechanical cues coordinate collectivity of movement of epithelial cells in response to injury by Menko, A.S., Bleaken, B.M., Walker, J.L.

“…This study investigates how epithelial cells moving together function to coordinate their collective movement to repair a wound. Using a lens ex vivo mock…”
Get full text

GOG 186H: A randomized phase II evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin) in the treatment of recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer by Cohn, D.E, Sill, M, Walker, J.L, O'Malley, D.M, Nagel, C.I, Rutledge, T, Bradley, W.H, Richardson, D.L, Moxley, K, Aghajanian, C

Get full text

Provision of “primary palliative care” by gynecologic oncologists by Rowland, M, Moore, K.N, Walker, J.L, Landrum, L.M, Matzo, M

Get full text

Identifying gynecologic oncology patients with high symptom burden by Ruskin, R, Moore, K.N, Walker, J.L, Landrum, L.M, Matzo, M

Get full text

Neoadjuvant chemotherapy for advanced ovarian, fallopian tube and peritoneal cancer: An ancillary study of GOG 262 by Chan, J.K, Brady, M.F, Penson, R.T, Monk, B.J, Kapp, D.S, Birrer, M.J, Huang, H, Walker, J.L, DiSilvestro, P.A, Rubin, S.C, Martin, L.P, Davidson, S.A, Huh, W.K, O'Malley, D.M, Boente, M.P, Michael, H

Get full text

Variations in patient preferences over side effects of treatments for ovarian cancer: Baseline results of a randomized controlled clinical trial by Mukamel, D.B, Wenzel, L, Havrilesky, L.J, Osann, K, Ladd, H.A, Walker, J.L, Wright, A.A, Alvarez, R.D, Bristow, R.E, DiSilvestro, P.A, Morgan, R.J, Lipscomb, J, Cohn, D.E

Get full text

Patterns of recurrence and survival after randomization to laparoscopy versus laparotomy in women with high-grade uterine cancer: A Gynecologic Oncology Group (GOG) study by Java, J, Tenney, M, Gunderson, C.C, Kushnir, C.L, Spirtos, N.M, Walker, J.L

Get full text

A phase II evaluation of sunitinib (SU11248) in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG) study by Chan, J, Brady, W.E, Brown, J, Shahin, M.S, Rose, P.G, Kim, J.H, Secord, A.A, Walker, J.L, Monk, B.J

Get full text

A phase III randomized controlled clinical trial of carboplatin and paclitaxel alone or in combination with bevacizumab followed by bevacizumab and secondary cytoreductive surgery in platinum-sensitive, recurrent ovarian, peritoneal primary and fallopian tube cancer (Gynecologic Oncology Group 0213) by Brady, M.F, Herzog, T.J, Sabbatini, P, Armstrong, D.K, Walker, J.L, Kim, B.G, Fujiwara, K, Tewari, K.S, O'Malley, D.M

Get full text

A phase III trial of maintenance therapy in women with advanced ovarian/fallopian tube/peritoneal cancer after a complete clinical response to first-line therapy: An NRG oncology study by Copeland, L.J, Brady, M.F, Burger, R.A, Rodgers, W.H, Huang, H, Cella, D, Fowler, J.M, Walker, J.L, Tewari, K.S, Bender, D.P, Morris, R.T, Lowery, W.J, Miller, D.S, Dewdney, S.B, Spirtos, N.M, Lele, S.B, Guntupalli, S.R, Ueland, F.R, Glaser, G.E, Mannel, R.S, DiSaia, P.J

Get full text

Reducing Heart Failure Readmissions Among Post Open Heart Surgical Patients by Walker, J.L, Nack, J.A, Buitrago, P, Parfitt, K

Get full text

Patient and physician factors associated with participation in Gynecologic Oncology Group (GOG) trials in cervical and uterine cancer by Carter, R.L, Plaxe, S.C, Basen-Engquist, K.M, Rodriguez, M, Walker, J.L, Myers, T.K.N, Drake, J.G, Havrilesky, L.J, Brown, C.L, Van Le, L, Landrum, L.M

Get full text

Health-related quality of life associated with every-3-week paclitaxel vs dose-dense weekly paclitaxel in combination with carboplatin with or without bevacizumab for primary ovarian cancer: Gynecologic Oncology Group study 262 by Huang, H, Penson, R.T, Davidson, S.A, Pearl, M.L, O'Malley, D.M, Bender, D.P, Boente, M.P, Martin, L.P, Chan, J.K, Walker, J.L, McCourt, C.K

Get full text

Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube, and peritoneal cancers by Java, J, Burger, R.A, Bookman, M.A, Fleming, G, Monk, B.J, Walker, J.L, Homesley, H.D, Fowler, J.M, Greer, B.E, Boente, M.P

Get full text

Applications of list decoding to tracing traitors by Silverberg, A., Staddon, J., Walker, J.L.

“…We apply results from algebraic coding theory to solve problems in cryptography, by using recent results on list decoding of error-correcting codes to…”
Get full text